Elicio Therapeutics News

Elicio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer DeMuth Peter

Dec 18, 2024 16:54 ET

Elicio Therapeutics | 8-K: Current report

Dec 12, 2024 07:11 ET

Elicio Therapeutics | 8-K: Current report

Dec 3, 2024 07:16 ET

Elicio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Venkatesan Jay

Nov 29, 2024 07:44 ET

Elicio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director WILSON KAREN J

Nov 25, 2024 16:07 ET

Elicio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director ADAMS JULIAN

Nov 25, 2024 07:42 ET

Elicio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Ashe Carol Gail

Nov 25, 2024 07:37 ET

Elicio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Venkatesan Jay

Nov 25, 2024 07:37 ET

Elicio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director RUFFOLO ROBERT R

Nov 25, 2024 07:37 ET

Elicio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Chudnovsky Yekaterina

Nov 25, 2024 07:37 ET

Elicio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Nissenson Allen

Nov 25, 2024 07:37 ET

Elicio Therapeutics | 424B3: Prospectus

Nov 22, 2024 08:10 ET

Elicio Therapeutics | 8-K: Current report

Nov 21, 2024 16:11 ET

Elicio Therapeutics | EFFECT: Others

Nov 21, 2024 06:05 ET

Elicio Therapeutics | CORRESP: CORRESP

Nov 18, 2024 11:53 ET

Elicio Therapeutics | UPLOAD: Others

Nov 15, 2024 11:53 ET

Elicio Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Nov 13, 2024 16:26 ET

Elicio Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 13, 2024 16:17 ET

Elicio Therapeutics | 8-K: Current report

Nov 13, 2024 16:16 ET

Elicio Therapeutics | 8-K: Current report

Nov 7, 2024 16:33 ET